ImmunityBio, Inc.IBRXNASDAQ
Loading
P/E Ratio: Premium ValuationElevated
Percentile Rank67
Studio
Year-over-Year Change

Price-to-earnings ratio

Latest
-5.18
↑ 51% vs avg
Percentile
P67
Within normal range
Streak
1 yr
Consecutive declineElevated
Average
-10.49
Historical baseline
PeriodValueYoY Change
2025-5.18-20.1%
2024-4.32+1.4%
2023-4.38+10.0%
2022-4.87+28.7%
2021-6.82+70.4%
2020-23.02-4.3%
2019-22.07-463.4%
2018-3.92+73.4%
2017-14.72+5.4%
2016-15.56-